99 related articles for article (PubMed ID: 1698449)
1. Parasite uptake of desferroxamine: a prerequisite for antimalarial activity.
Scott MD; Ranz A; Kuypers FA; Lubin BH; Meshnick SR
Br J Haematol; 1990 Aug; 75(4):598-602. PubMed ID: 1698449
[TBL] [Abstract][Full Text] [Related]
2. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators.
Loyevsky M; John C; Dickens B; Hu V; Miller JH; Gordeuk VR
Mol Biochem Parasitol; 1999 Jun; 101(1-2):43-59. PubMed ID: 10413042
[TBL] [Abstract][Full Text] [Related]
3. Malaria pigment and extracellular iron. Possible target for iron chelating agents.
van Zyl RL; Havlik I; Hempelmann E; MacPhail AP; McNamara L
Biochem Pharmacol; 1993 Apr; 45(7):1431-6. PubMed ID: 8471067
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
[TBL] [Abstract][Full Text] [Related]
5. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.
Loyevsky M; Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
J Clin Invest; 1993 Jan; 91(1):218-24. PubMed ID: 8423220
[TBL] [Abstract][Full Text] [Related]
6. Assessment of antimalarial effect of ICL670A on in vitro cultures of Plasmodium falciparum.
Goudeau C; Loyevsky M; Kassim OO; Gordeuk VR; Nick H
Br J Haematol; 2001 Dec; 115(4):918-23. PubMed ID: 11843826
[TBL] [Abstract][Full Text] [Related]
7. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
Pattanapanyasat K; Kotipun K; Yongvanitchit K; Hider RC; Kyle DE; Heppner DG; Walsh DS
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):64-9. PubMed ID: 11485097
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial action of hydrophilic drugs: involvement of aqueous access routes to intracellular parasites.
Loyevsky M; Cabantchik ZI
Mol Pharmacol; 1994 Mar; 45(3):446-52. PubMed ID: 8145731
[TBL] [Abstract][Full Text] [Related]
9. In vitro antimalarial effect of daphnetin relating to its iron-chelating activity.
Mu LY; Wang QM; Ni YC
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(2):83-5. PubMed ID: 12567565
[TBL] [Abstract][Full Text] [Related]
10. 14C-desferrioxamine B: uptake into erythrocytes infected with Plasmodium falciparum.
Fritsch G; Jung A
Z Parasitenkd; 1986; 72(6):709-13. PubMed ID: 3541423
[TBL] [Abstract][Full Text] [Related]
11. Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.
Lytton SD; Mester B; Dayan I; Glickstein H; Libman J; Shanzer A; Cabantchik ZI
Blood; 1993 Jan; 81(1):214-21. PubMed ID: 8417790
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial activity of selected aromatic chelators V. Localization of 59Fe in Plasmodium falciparum in the presence of oxines.
Scheibel LW; Rodriguez S
Prog Clin Biol Res; 1989; 313():119-49. PubMed ID: 2506579
[No Abstract] [Full Text] [Related]
13. Reversed siderophores act as antimalarial agents.
Shanzer A; Libman J; Lytton SD; Glickstein H; Cabantchik ZI
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6585-9. PubMed ID: 1862083
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial activity of selected aromatic chelators. IV. Cation uptake by Plasmodium falciparum in the presence of oxines and siderochromes.
Scheibel LW; Stanton GG
Mol Pharmacol; 1986 Oct; 30(4):364-9. PubMed ID: 2945090
[TBL] [Abstract][Full Text] [Related]
15. Iron chelation therapy for malaria: a review.
Mabeza GF; Loyevsky M; Gordeuk VR; Weiss G
Pharmacol Ther; 1999 Jan; 81(1):53-75. PubMed ID: 10051178
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin.
Fritsch G; Sawatzki G; Treumer J; Jung A; Spira DT
Exp Parasitol; 1987 Feb; 63(1):1-9. PubMed ID: 3542546
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial iron chelator FBS0701 blocks transmission by Plasmodium falciparum gametocyte activation inhibition.
Ferrer P; Vega-Rodriguez J; Tripathi AK; Jacobs-Lorena M; Sullivan DJ
Antimicrob Agents Chemother; 2015 Mar; 59(3):1418-26. PubMed ID: 25512427
[TBL] [Abstract][Full Text] [Related]
18. Concurrent inhibition by tunicamycin of glycosylation and parasitemia in malarial parasites (Plasmodium falciparum) cultured in human erythrocytes.
Udeinya IJ; Van Dyke K
Pharmacology; 1981; 23(3):165-70. PubMed ID: 7025026
[TBL] [Abstract][Full Text] [Related]
19. Iron chelation therapy for malaria.
Gordeuk VR; Thuma PE; Brittenham GM
Adv Exp Med Biol; 1994; 356():371-83. PubMed ID: 7887243
[No Abstract] [Full Text] [Related]
20. Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection.
Fritsche G; Larcher C; Schennach H; Weiss G
J Infect Dis; 2001 May; 183(9):1388-94. PubMed ID: 11294671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
